Medications

US health watchdog rejects Sanofi's MS drug

French drug giant Sanofi announced Monday US health authorities had rejected its Lemtrada drug for some forms of multiple sclerosis, which is already approved in the European Union, Canada and Australia.

Neuroscience

Simple eye test diagnoses multiple sclerosis

(Medical Xpress)—As you step outdoors into the bright sunshine, your pupils automatically contract. Scientists from the Australian Centre of Excellence in Vision Science (ACEVS) based at The Australian National University ...

Neuroscience

Could a vaccine help ward off multiple sclerosis?

A vaccine used to prevent tuberculosis in other parts of the world may help prevent multiple sclerosis (MS) in people who show the beginning signs of the disease, according to a new study published in the December 4, 2013, ...

Health

Czechs in quandary over legal medical marijuana

(AP)—Just three years ago, the only thing that Zdenek Majzlik knew about cannabis was that it's good stuff for making rope. Today, the 67-year-old retired nuclear power plant employee is an experienced grower who cultivates ...

Oncology & Cancer

Tackling a large challenge for new modes of drug delivery

New treatments for prostate cancer, multiple sclerosis and cystic fibrosis could be developed following research being carried out into how medicinal 'biologics' can be delivered to diseased cells.

Neuroscience

Quantity, not just quality, in new Stanford brain scan method

(Medical Xpress)—Imagine that your mechanic tells you that your brake pads seem thin, but doesn't know how long they will last. Or that your doctor says your child has a temperature, but isn't sure how high. Quantitative ...

page 36 from 40